Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Microsimulation Modeling in Oncology

Microsimulation Modeling in Oncology Purpose: Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the simulation of downstream events on the basis of predefined states and transition probabilities between those states over time. In this article, we describe the history of the role of microsimulation in medicine and its potential applications in oncology as useful tools for population risk stratification and treatment strategy design for precision medicine. Methods: We conducted a comprehensive and methodical search of the literature using electronic databases-Medline, Embase, and Cochrane-for works published between 1985 and 2016. A medical subject heading search strategy was constructed for Medline searches by using a combination of relevant search terms, such as "microsimulation model medicine," "multistate modeling cancer," and "oncology." Results: Microsimulation modeling is particularly useful for the study of optimal intervention strategies when randomized control trials may not be feasible, ethical, or practical. Microsimulation models can retain memory of prior behaviors and states. As such, it allows an explicit representation and understanding of how various processes propagate over time and affect the final outcomes for an individual or in a population. Conclusion: A well-calibrated microsimulation model can be used to predict the outcome of the event of interest for a new individual or subpopulations, assess the effectiveness and cost effectiveness of alternative interventions, and project the future disease burden of oncologic diseases. In the growing field of oncology research, a microsimulation model can serve as a valuable tool among the various facets of methodology available. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JCO Clinical Cancer Informatics Wolters Kluwer Health

Microsimulation Modeling in Oncology

Download PDF
11 pages

Loading next page...
 
/lp/wolters-kluwer-health/microsimulation-modeling-in-oncology-b1NGX97Dj0
Publisher
Wolters Kluwer Health
Copyright
(C) 2018 by Lippincott Williams & Wilkins, Inc.
ISSN
2473-4276
DOI
10.1200/CCI.17.00029
Publisher site
See Article on Publisher Site

Abstract

Purpose: Microsimulation is a modeling technique that uses a sample size of individual units (microunits), each with a unique set of attributes, and allows for the simulation of downstream events on the basis of predefined states and transition probabilities between those states over time. In this article, we describe the history of the role of microsimulation in medicine and its potential applications in oncology as useful tools for population risk stratification and treatment strategy design for precision medicine. Methods: We conducted a comprehensive and methodical search of the literature using electronic databases-Medline, Embase, and Cochrane-for works published between 1985 and 2016. A medical subject heading search strategy was constructed for Medline searches by using a combination of relevant search terms, such as "microsimulation model medicine," "multistate modeling cancer," and "oncology." Results: Microsimulation modeling is particularly useful for the study of optimal intervention strategies when randomized control trials may not be feasible, ethical, or practical. Microsimulation models can retain memory of prior behaviors and states. As such, it allows an explicit representation and understanding of how various processes propagate over time and affect the final outcomes for an individual or in a population. Conclusion: A well-calibrated microsimulation model can be used to predict the outcome of the event of interest for a new individual or subpopulations, assess the effectiveness and cost effectiveness of alternative interventions, and project the future disease burden of oncologic diseases. In the growing field of oncology research, a microsimulation model can serve as a valuable tool among the various facets of methodology available.

Journal

JCO Clinical Cancer Informatics – Wolters Kluwer Health

Published: Mar 1, 2018

References

  • Cancer Intervention and Surveillance Modeling Network
    National Cancer Institute
  • What is dynamic social science microsimulation
    Statistics Canada
  • Decision analysis
    Pauker SG; Kassirer JP
  • The Population Health Model (POHEM): An overview of rationale, methods and applications
    Hennessy DA; Flanagan WM; Tanuseputro P
  • Assessing uncertainty in microsimulation modelling with application to cancer screening interventions
    Cronin KA; Legler JM; Etzioni RD
  • Calibration of disease simulation model using an engineering approach
    Kong CY; McMahon PM; Gazelle GS
  • The development and validation of a decision-analytic model representing the full disease course of acute myeloid leukemia
    Leunis A; Redekop WK; van Montfort KA
  • Response: Reading between the lines of cancer screening trials: Using modeling to understand the evidence
    Etzioni R; Gulati R
  • Initial management strategies for follicular lymphoma
    Chen Q; Ayer T; Nastoupil LJ
  • Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms
    Mandelblatt JS; Cronin KA; Bailey S
  • Evaluating test strategies for colorectal cancer screening: A decision analysis for the U
    Zauber AG; Lansdorp-Vogelaar I; Knudsen AB
  • National Cancer Database
    American College of Physicians
  • About the SEER program
    National Cancer Institute
  • SEER-Medicare: Brief description of the SEER-Medicare database
    National Cancer Institute
  • Modeling good research practices-verview: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1
    Caro JJ; Briggs AH; Siebert U
  • Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials
    Meza R; ten Haaf K; Kong CY
  • Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: Model estimates of potential benefits and harms
    Gulati R; Gore JL; Etzioni R
  • Is prostate cancer screening cost-effective
    Pataky R; Gulati R; Etzioni R
  • A comparative review of CISNET breast models used to analyze U
    Clarke LD; Plevritis SK; Boer R
  • The Wisconsin breast cancer epidemiology simulation model
    Fryback DG; Stout NK; Rosenberg MA
  • Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society
    Oeffinger KC; Fontham ET; Etzioni R
  • An evidence-based microsimulation model for colorectal cancer: Validation and application
    Rutter CM; Savarino JE
  • Does a negative screening colonoscopy ever need to be repeated
    Brenner H; Chang-Claude J; Seiler CM
  • Five-year risk of colorectal neoplasia after negative screening colonoscopy
    Imperiale TF; Glowinski EA; Lin-Cooper C
  • Simulation-based estimation of stochastic process parameters in tumor growth
    Thompson JR
  • Model transparency and validation: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
    Eddy DM; Hollingworth W; Caro JJ
  • Model parameter estimation and uncertainty: A report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
    Briggs AH; Weinstein MC; Fenwick EA
  • Breast Cancer Risk Assessment Tool
    National Cancer Institute